|By Business Wire||
|August 12, 2014 03:56 AM EDT||
Research and Markets (http://www.researchandmarkets.com/research/4bzxnc/nanobiotechnology) has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering.
An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug development - from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based on nanobiotechnology will enable high-throughput screening. Some of nanostructures such as fullerenes are themselves drug candidates as they allow precise grafting of active chemical groups in three-dimensional orientations. The most important pharmaceutical applications are in drug delivery. Apart from offering a solution to solubility problems, nanobiotechnology provides and intracellular delivery possibilities. Skin penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices with autonomous operation guided by the needs.
Future nanobiotechnology markets are calculated on the basis of the background markets in the areas of application and the share of this market by new technologies and state of development at any given year in the future. This is based on a comprehensive and thorough review of the current status of nanobiotechnology, research work in progress and anticipated progress. There is definite indication of large growth of the market but it will be uneven and cannot be plotted as a steady growth curve. Marketing estimates are given according to areas of application, technologies and geographical distribution starting with 2013. The largest expansion is expected between the years 2018 and 2023.
Profiles of 247 companies, out of over 500 involved in this area, are included in the last chapter along with their 17 collaborations. The report is supplemented with 41 Tables, 24 figures and 800 references to the literature.
Key Topics Covered:
3. Nanotechnologies for Basic Research Relevant to Medicine
4. Nanomolecular Diagnostics
6. Role of Nanotechnology in Biological Therapies
7. Nanodevices & Techniques for Clinical Applications
15. Miscellaneous Healthcare Applications of Nanobiotechnology
16. Nanobiotechnology and Personalized Medicine
18. Ethical and Regulatory Aspects of Nanomedicine
19. Research and Future of Nanomedicine
20. Nanobiotechnology Markets
For more information visit http://www.researchandmarkets.com/research/4bzxnc/nanobiotechnology
Source: Jain PharmaBiotech
Oct. 25, 2016 01:15 PM EDT Reads: 1,034
Oct. 25, 2016 12:45 PM EDT Reads: 4,928
Oct. 25, 2016 12:30 PM EDT Reads: 8,474
Oct. 25, 2016 12:00 PM EDT Reads: 2,667
Oct. 25, 2016 11:45 AM EDT Reads: 3,796
Oct. 25, 2016 11:45 AM EDT Reads: 2,087
Oct. 25, 2016 11:45 AM EDT Reads: 2,163
Oct. 25, 2016 11:42 AM EDT Reads: 161
Oct. 25, 2016 11:30 AM EDT Reads: 2,020
Oct. 25, 2016 11:30 AM EDT Reads: 1,117
Oct. 25, 2016 11:30 AM EDT Reads: 3,598
Oct. 25, 2016 11:15 AM EDT Reads: 1,522
SYS-CON Events announced today that Tintri Inc., a leading producer of VM-aware storage (VAS) for virtualization and cloud environments, will present at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Tintri VM-aware storage is the simplest for virtualized applications and cloud. Organizations including GE, Toyota, United Healthcare, NASA and 6 of the Fortune 15 have said “No to LUNs.” With Tintri they manag...
Oct. 25, 2016 11:15 AM EDT Reads: 3,643
Oct. 25, 2016 11:15 AM EDT Reads: 3,920
From wearable activity trackers to fantasy e-sports, data and technology are transforming the way athletes train for the game and fans engage with their teams. In his session at @ThingsExpo, will present key data findings from leading sports organizations San Francisco 49ers, Orlando Magic NBA team. By utilizing data analytics these sports orgs have recognized new revenue streams, doubled its fan base and streamlined costs at its stadiums. John Paul is the CEO and Founder of VenueNext. Prior ...
Oct. 25, 2016 11:00 AM EDT Reads: 3,681